Etodolac Production Cost Reports

The report provides a detailed analysis essential for establishing an Etodolac production plant. It encompasses all critical aspects necessary for Etodolac production, including the cost of Etodolac production, Etodolac plant cost, Etodolac production costs, and the overall Etodolac production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Etodolac production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) primarily used as an active pharmaceutical ingredient for treating mild to moderate pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and acute pain conditions. Its therapeutic effect comes from selectively inhibiting cyclooxygenase-2 (COX-2) enzyme, reducing prostaglandin synthesis that causes pain and inflammation. It is manufactured as tablets, capsules, and advanced drug delivery forms like transdermal systems for both human and veterinary uses.

The Etodolac market is driven primarily by the increasing global prevalence of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis, which generate sustained demand for effective pain management solutions. The ageing global population further fuels this demand, with the number of elderly individuals growing significantly worldwide. Rising patient and healthcare provider awareness about pain management and the availability of cost-effective generic Etodolac.

Raw Material for Etodolac Production

According to the Etodolac production plant project report, the various raw materials for Etodolac production include 7-ethyltryptophol and methyl 3-oxopentanoate.

Production Process of Etodolac

The extensive Etodolac production cost report consists of the following major industrial production process:

1. Production from 7-ethyltryptophol: The production process of Etodolac involves reacting 7-ethyltryptophol with methyl 3-oxopentanoate in an apolar solvent such as toluene. The reaction occurs in the presence of a concentrated mineral acid like hydrochloric or sulfuric acid, at controlled temperatures between -20 degree Celsius to +50 degree Celsius. This reaction forms an intermediate methyl ester compound, which is subsequently hydrolysed to yield Etodolac.

Properties of Etodolac

Etodolac is a white crystalline solid with a molecular formula of C17H21NO3 and a molecular weight of 287.35 g/mol. It has a melting point in the range of 145-148 degree Celsius. Etodolac is slightly soluble in water but soluble in alcohols, chloroform, dimethyl sulfoxide, and aqueous polyethylene glycol. It has an n-octanol/water partition coefficient indicating moderate lipophilicity, with values reported around 2.5 to 11.4 depending on the pH and study conditions. It is a pyranocarboxylic acid NSAID with an indole-pyran ring structure and possesses one chiral centre. Its pKa is about 4.31 to 4.65, reflecting its acidic character. Etodolac acts as a selective cyclooxygenase-2 (COX-2) inhibitor, producing anti-inflammatory, analgesic, and antipyretic effects. The compound is stable under refrigerated storage and is slightly sensitive to heat.